QUOTE
ZymoGenetics, Inc. (ZGEN)
$
9.76
 $0.01 (0.10%) Oct 12
|
1201 Eastlake Avenue East
,
Seattle,
WA
98102
,
USA
+1-206-442-6600
http://www.zymogenetics.com/ |
|
|
| PRICES |
| Open |
Volume |
| 9.74 |
254,100 |
| High |
Low |
| 9.76 |
9.74 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| n/a |
9.03M |
| 52wk High |
52wk Low |
| 0.00 |
0.00 |
|
| RATIOS |
| P/E |
EPS |
| n/a |
n/a |
| BV |
P/BV |
| n/a |
n/a |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| n/a |
n/a |
| Shares |
Inst Owner |
| n/a |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 |
| Income statement |
| Total Revenue |
$25.96 | $35.69 | $42.91 | $25.38 | $38.48 | $73.99 |
| Operating Income |
$-60.40 | $-86.89 | $-80.03 | $-136.29 | $-150.75 | $-118.60 |
| Net Income |
$-59.57 | $-88.76 | $-78.03 | $-130 | $-148.14 | $-116.24 |
| Balance Sheet |
| Total Assets |
$375.91 | $412.18 | $453.35 | $347 | $263.08 | $210.05 |
| Total Equity |
$287.92 | $278.55 | $333.66 | $235.68 | $114.83 | $23.36 |
| Total Liabilities |
$87.99 | $133.63 | $119.69 | $111.32 | $148.25 | $186.69 |
| Cash Flow |
| Operating |
$-49.79 | $-31.95 | $-81.62 | $-113.75 | $-87.50 | $-109.64 |
| Investing |
$10.50 | $-27.17 | $-43.81 | $-14.01 | $106.12 | $106.27 |
| Financing |
$81.29 | $78.85 | $130.45 | $11.01 | $5.04 | $24.23 |
| Net Cash Change |
$42 | $19.73 | $5.01 | $-116.75 | $23.66 | $20.85 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
11 February 2010
04 May 2010
03 August 2010
|
11 February 2009
05 May 2009
03 August 2009
05 November 2009
|
13 February 2008
06 May 2008
05 August 2008
04 November 2008
|
02 May 2007
01 August 2007
31 October 2007
|
| |
|
| Earning Call Summary |
Transcripts |
| |
|
| 10K Reports |
Annual Reports |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Ticker News
|
|
| |
| |
| | | |
Management
|
|
Executive |
Title |
|
Bruce L. Carter |
Chairman of the Board, Chief Executive Officer | |
|
Judith A. Hemberger |
Director |
|
Douglas E. Williams |
President and Chief Scientific Officer |
|
James A. Johnson |
Chief Financial Officer, Executive Vice President, Treasurer |
|
Suzanne M. Shema |
Senior Vice President and General Counsel, Law and Compliance |
|
Michael Dwyer |
Senior Vice President - Sales and Marketing |
|
Vaughn B. Himes |
Senior Vice President - Technical Operations |
|
Nicole M. Onetto |
Senior Vice President, Chief Medical Officer |
|
Heather L. Franklin |
Senior Vice President, Business Development |
|
Darren R. Hamby |
Senior Vice President - Human Resources |
|
|
|
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites. Market data: BATS Exchange. Inc
